Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

What Are the Top COVID Plays for 2022?


Will COVID-19 be finished in 2022? That would be nice. If the vaccines work and we develop "herd immunity," COVID will certainly recede in importance. It will be more like the flu, and many of us will get vaccinated every year to stay safe. So how should investors play this transition?

Three Fool.com contributors have three different approaches for the new year. Here's why they like Pfizer (NYSE: PFE), Novavax (NASDAQ: NVAX), and Live Nation Entertainment (NYSE: LYV) in 2022 and beyond.

Image source: Getty Images.

Continue reading


Source Fool.com

Like: 0
PFE
Share

Comments